These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 11817712

  • 1. Effects of 17beta-estradiol on the expression of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 in human osteoblastic MG-63 cell cultures.
    Liao EY, Luo XH, Deng XG, Wu XP.
    J Endocrinol Invest; 2001 Dec; 24(11):876-81. PubMed ID: 11817712
    [Abstract] [Full Text] [Related]

  • 2. Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1 -MMP) compartment of proMMP-2 activation in MG-63 cells.
    Luo XH, Liao EY.
    Horm Metab Res; 2001 Jul; 33(7):383-8. PubMed ID: 11507673
    [Abstract] [Full Text] [Related]

  • 3. Membrane-type matrix metalloproteinase-1 (MT1-MMP) is down-regulated in estrogen-deficient rat osteoblast in vivo.
    Liao EY, Liao HJ, Guo LJ, Zhou HD, Wu XP, Dai RC, Luo XH.
    J Endocrinol Invest; 2004 Jan; 27(1):1-5. PubMed ID: 15053235
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knäuper V.
    Biochem J; 2003 Jun 15; 372(Pt 3):799-809. PubMed ID: 12630911
    [Abstract] [Full Text] [Related]

  • 6. Role of PKC-α in NF-κB-MT1-MMP-mediated activation of proMMP-2 by TNF-α in pulmonary artery smooth muscle cells.
    Roy S, Chakraborti T, Chowdhury A, Chakraborti S.
    J Biochem; 2013 Mar 15; 153(3):289-302. PubMed ID: 23266860
    [Abstract] [Full Text] [Related]

  • 7. Parathyroid hormone inhibits the expression of membrane-type matrix metalloproteinase-1 (MT1-MMP) in osteoblast-like MG-63 cells.
    Luo XH, Liao EY, Su X, Wu XP.
    J Bone Miner Metab; 2004 Mar 15; 22(1):19-25. PubMed ID: 14691682
    [Abstract] [Full Text] [Related]

  • 8. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
    Monea S, Lehti K, Keski-Oja J, Mignatti P.
    J Cell Physiol; 2002 Aug 15; 192(2):160-70. PubMed ID: 12115722
    [Abstract] [Full Text] [Related]

  • 9. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
    Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M, Okada Y.
    Cancer Res; 1997 May 15; 57(10):2055-60. PubMed ID: 9158005
    [Abstract] [Full Text] [Related]

  • 10. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.
    Sato T, Sakai T, Noguchi Y, Takita M, Hirakawa S, Ito A.
    Gynecol Oncol; 2004 Jan 15; 92(1):47-56. PubMed ID: 14751137
    [Abstract] [Full Text] [Related]

  • 11. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines.
    Kurschat P, Zigrino P, Nischt R, Breitkopf K, Steurer P, Klein CE, Krieg T, Mauch C.
    J Biol Chem; 1999 Jul 23; 274(30):21056-62. PubMed ID: 10409657
    [Abstract] [Full Text] [Related]

  • 12. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
    Bernardo MM, Fridman R.
    Biochem J; 2003 Sep 15; 374(Pt 3):739-45. PubMed ID: 12755684
    [Abstract] [Full Text] [Related]

  • 13. Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13.
    Knäuper V, Bailey L, Worley JR, Soloway P, Patterson ML, Murphy G.
    FEBS Lett; 2002 Dec 04; 532(1-2):127-30. PubMed ID: 12459476
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts.
    Sato T, Iwai M, Sakai T, Sato H, Seiki M, Mori Y, Ito A.
    Br J Cancer; 1999 Jun 04; 80(8):1137-43. PubMed ID: 10376963
    [Abstract] [Full Text] [Related]

  • 15. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
    Lehti K, Lohi J, Valtanen H, Keski-Oja J.
    Biochem J; 1998 Sep 01; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
    [Abstract] [Full Text] [Related]

  • 16. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis.
    Shimada T, Nakamura H, Yamashita K, Kawata R, Murakami Y, Fujimoto N, Sato H, Seiki M, Okada Y.
    Clin Exp Metastasis; 2000 Sep 01; 18(2):179-88. PubMed ID: 11235994
    [Abstract] [Full Text] [Related]

  • 17. 1alpha,25-dihydroxyvitamin D3 regulates the expression of membrane-type matrix metalloproteinase-1 in normal human osteoblast-like cells.
    Luo XH, Liao EY.
    Endocr Res; 2003 Aug 01; 29(3):353-62. PubMed ID: 14535636
    [Abstract] [Full Text] [Related]

  • 18. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes.
    Baumann P, Zigrino P, Mauch C, Breitkreutz D, Nischt R.
    Br J Cancer; 2000 Nov 01; 83(10):1387-93. PubMed ID: 11044366
    [Abstract] [Full Text] [Related]

  • 19. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
    Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, Seiki M.
    EMBO J; 2001 Sep 03; 20(17):4782-93. PubMed ID: 11532942
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of matrix metalloproteinase-14 in osteosarcoma cells by clodronate.
    Heikkilä P, Teronen O, Hirn MY, Sorsa T, Tervahartiala T, Salo T, Konttinen YT, Halttunen T, Moilanen M, Hanemaaijer R, Laitinen M.
    J Surg Res; 2003 May 01; 111(1):45-52. PubMed ID: 12842447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.